ArticleRSC advances2020

Antiviral agents against COVID-19: structure-based design of specific peptidomimetic inhibitors of SARS-CoV-2 main protease.

Vladimir Frecer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.